Affiliations: New Rochelle, NY;
Adrienne Wald, RN, MBA, 40 Brookside Place, New Rochelle, NY 10801; e-mail: email@example.com,
Hyogo Medical Center
Noriaki Tsubota, MD, PhD, Hyogo Medical Center, General Thoracic Surgery, Akashi, Kitaoji 13–70 Hyogo, Japan; e-mail: firstname.lastname@example.org,
The Oregon Clinic
To the Editor:
In the article by Minami et al (December
2000),1 in Table 1, in the“
Complete Resection” line, the numbers that are shown (249 [79.6]
and 654 [85.2]) seem to be erroneous. I get 72.2 and 73.8. Am I
missing something or can you please explain? This is a key figure in
In the article by Asaph et al (December 2000),2 in Table
1, the line under “Bronchoscopy” that reads “negative” shows a
figure of 15 (41); on page 1623, line 7, the following statement
appears: “second neoplasm was confirmed in 15 patients (40.5%; Table
1).” If it was confirmed, it should be positive. Is the figure
correct in the table or is the text worded correctly?
I appreciate your assistance.
We thank Ms Wald for her close attention on our
article.1 The number she points out is not an error, but
it is easily misunderstood due to lack of the words “without
induction therapy.” Complete resection was estimated in 249 of 313
women and in 654 of 768 men without induction therapy. We calculated
the percentage of complete resection in 249/313 (79.6%) and
654/768 (85.2%) for the patients without induction therapy, not
249/337 or 905/954.
The main finding is that T4 (malignant effusion)
in lung cancer is encountered more often in women than in men.
Malignancy cannot be judged correctly only from completely resected
Thanks to Ms. Wald for careful reading of our
article.1 In fact, Table 1 of that article is correct, in
that 13 positive bronchoscopies were found in 28 total bronchoscopies.
This finding reflects the earlier-stage patients who have peripheral
nodules and who are submitted to bronchoscopy to help separate this
histology from the original. We will submit an erratum (page 325) to
change the text to read “in which the second neoplasm was confirmed
in 13 patients (46% of those receiving bronchoscopy).”
Become a CHEST member and receive a FREE subscription as a benefit of membership.
Individuals can purchase this article on ScienceDirect.
Individuals can purchase a subscription to the journal.
Individuals can purchase a subscription to the journal or buy individual articles.
Learn more about membership or Purchase a Full Subscription.
Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited:
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.